Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Cooleys Anemia Foundation

Celgene building

Celgene bags US priority review for cancer metabolism drug

First approval for enasidenib could be just six months away

Takeda pilots Apple Watch depression app

Partners with Cognition Kit on patient monitoring wearable

- PMLiVE

Celgene’s president and COO to retire

Scott Smith set to succeed Dr Jacqualyn Fouse from 1 April

- PMLiVE

Riding the wave of digital disruption

The challenges and rewards of meeting consumer expectations

- PMLiVE

New philosophies driving transformative healthcare

The key trends and philosophies driving this disruptive and innovative era of healthcare forward

- PMLiVE

Mining for results

How one tech firm is working with Big Data

- PMLiVE

Trump talks pricing and manufacturing with pharma

Heads of Celgene, Lilly, Merck & Co, Novartis and trade body PhRMA met at the White House

Celgene building

Celgene pays $300m upfront for immunology start-up Delinia

Broadens its pipeline with autoimmune disease candidate due to start trials in 2018

- PMLiVE

The reality of real-world evidence

Despite a slow uptake of RWE, there is an increasing trend in the use of healthcare system data to inform clinical practice

- PMLiVE

The digital race: Eight ways to get up-to-speed

The festive season is over, so why does analysis of pharma’s digital progress feel like a Christmas repeat of Groundhog Day? Here are eight ideas to stop next year feeling like...

- PMLiVE

Real-world evidence

Companies are now recruiting high-level executives to lead well-resourced RWE teams as industry looks to reshape the future

- PMLiVE

Celgene bid to push Revlimid beyond myeloma blocked again

Cancer treatment fails phase III trial in lymphoma

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links